老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
抗疫概念
884.588
+6.101
0.69%
手動刷新
漲家數:
10
跌家數:
7
平家數:
- -
市盈率:
- -
高:
886.877
開:
878.433
低:
868.104
收:
878.487
成交量:
1.97億
成交額:
14.41億
市值:
5,975.51億
流通市值:
4,950.85億
資料載入中...
總覽
新聞資訊
港股異動 | 四環醫藥(00460)午前漲近4% 軒竹生物與INNOBIC就吡洛西利於泰國市場達成商業化合作
智通财经
·
09/04
連虧7年半股迪哲醫藥董事長擬減持 A股募資39億零派息
中金财经
·
09/04
中生製藥(01177.HK)GPC3 ADC臨床試驗申請獲FDA批准
阿斯达克财经
·
09/04
【券商聚焦】交銀國際:醫藥行業收入穩健增長 多重利好推動盈利表現顯著改善
金吾财讯
·
09/04
勁方醫藥-B(02595)存倉市值總計19.55億港元 股東將4373.09萬股股票存入渣打銀行(香港)
智通财经
·
09/04
醫藥代表退場,基藥目錄「及時雨」能否解藥企之渴?
蓝鲸财经
·
09/03
白雲山:2026年半年度權益分派實施公告
证券日报网
·
09/03
九州通與京東健康簽署戰略合作協議
南方财经网
·
09/03
王磊增持華潤萬象生活(01209)5萬股 每股作價38.52港元
智通财经
·
09/03
勁方醫藥-B(02595)9月3日斥資54.64萬港元回購2萬股
智通财经
·
09/03
白雲山:每股派0.30元,股權登記日為9月9日
南方财经网
·
09/03
貝萊德在國藥控股的H股好倉比例下降0.18%至8.93%
南方财经网
·
09/03
復星醫藥(02196.HK):蘆沃美替尼片新增適應症獲註冊批准
智通财经
·
09/03
復星醫藥(600196.SH)子公司蘆沃美替尼片新增適應症獲註冊批准
智通财经
·
09/03
港股異動 | 同源康醫藥-B(02410)午後升逾9% EGFR-TKI氘申艾替尼獲批一線治療晚期非小細胞肺癌
智通财经
·
09/03
大行評級丨高盛:下調歌禮制藥目標價至13.86港元,維持「中性」評級
格隆汇
·
09/03
同仁堂科技:營銷體系再升級 品種全生命周期管理提質增效
证券日报
·
09/03
《半日速報》恒指半日收報25,317點 升6點; 恒生科技指數半日收報4,491點 跌25點 平安升逾3% 小米集團跌逾3% 卓越睿新、德翔海運、TCL電子創新高
阿斯达克财经
·
09/03
星展銀行上調比亞迪電子目標價至40港元
格隆汇
·
09/03
港股異動 | 石藥集團(01093)升逾4% SYS6010近日再獲國家藥監局納入突破性治療品種名單
智通财经
·
09/03
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1515/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":884.58813,"timestamp":1789629273069,"preClose":878.48724,"halted":0,"volume":197206637,"delay":0,"changeRate":0.006945,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":6.100891,"latestTime":"09-17 15:14:33","open":878.4325,"high":886.8771,"low":868.10425,"amount":1441326389,"amplitude":0.021369,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789632600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":1.317311,"peRate":17.071131,"turnoverRate":0.002702,"increases":10,"decrements":7,"flats":0,"marketCap":597551097344,"floatMarketCap":495084888768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":886.8771,"amplitude":0.021369,"preClose":878.48724,"low":868.10425,"pbRate":"1.317311","latestPrice":884.58813,"volume":197206637,"delay":0,"open":878.4325,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":890.408,"twentyDayClose":941.274,"sixtyDayClose":813.549,"secType":"PLATE","market":"HK","turnoverRate":0.002702,"peRate":17.071131,"marketCap":597551097344,"floatMarketCap":495084888768,"timestamp":1789629273069,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":10,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664386607","title":"港股異動 | 四環醫藥(00460)午前漲近4% 軒竹生物與INNOBIC就吡洛西利於泰國市場達成商業化合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386607","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386607?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 11:52","pubTimestamp":1788493955,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,四环医药午前涨近4%,截至发稿,涨3.92%,报0.795港元,成交额981.3万港元。Innobic(亚洲)将作为经销商,负责目标产品于目标区域的药品注册、本地市场营销及商业化运营。轩竹生物将按约定供货价格供应目标产品,以支持目标产品在目标区域的商业化活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491955.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00460","BK1191","BK4585","BK1600","VXUS","BK1515","BK1593","BK4588","KCAI","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138500","title":"連虧7年半股迪哲醫藥董事長擬減持 A股募資39億零派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138500","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138500?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 11:34","pubTimestamp":1788492846,"startTime":"0","endTime":"0","summary":"中国经济网北京9月4日讯 迪哲医药 昨日晚间发布关于董事、高级管理人员减持股份计划公告。 迪哲医药称,上述减持对象本次减持数量占其本人本次减持前所持有公司股份数量均不超过25%。 截至减持股份计划预披露公告发布前最后一个交易日,即2026年9月3日,迪哲医药收报60.08元,以此计算,上述减持主体本次减持金额合计预计为2.17亿元。 经计算,迪哲医药上述两次募集资金金额合计为38.99亿元。 迪哲医药自上市以来未分红。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260904/32360003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03130","BK1515","BK4585","399300","83188","02827","02846","BK1161","BK1147","07233","BK4588","BK1574","83130","03188","159982","VIG","82846","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664241388","title":"中生製藥(01177.HK)GPC3 ADC臨床試驗申請獲FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664241388","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664241388?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:24","pubTimestamp":1788485040,"startTime":"0","endTime":"0","summary":"中国生物制药(01177.HK) 公布,集团附属公司正大天晴自主研发的国家1类新药TQB6426“GPC3抗体药物偶联物(ADC)”已获得美国食品药品监督管理局(FDA)的新药临床试验(IND)批准,拟用于晚期恶性肿瘤。目前,全球尚无靶向GPC3的ADC药物获批上市,同类候选产品整体处于临床前及早期临床探索阶段。集团将加速TQB6426的I期临床试验,评估其在晚期恶性肿瘤患者中的安全性、耐受性、药代动力学特征及初步疗效,尽早为全球肝细胞癌及更多实体瘤患者提供新的治疗选择。(sl/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-03 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542877/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542877/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1191","BK1515","BK1589","BK1521","01477","01177","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238859","title":"【券商聚焦】交銀國際:醫藥行業收入穩健增長 多重利好推動盈利表現顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238859","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664238859?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 09:00","pubTimestamp":1788483634,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示,1H26港股/A股医药行业整体收入增长4.7%/3.2%。创新药产业链增速领跑行业,服务板块复苏:1)港股/A股CXO收入整体增长29.2%/25.3%,(扣非)净利润增长23.4%/67.6%,在各子板块中增速最快,行业整体景气度和订单需求处于高位。2)核心成药板块收入增长17.8%/3.4%、利润增长62.7%/35.0%。其中生物药增速远超化药,在板块收入中的占比也进一步提升。3)医院、器械、诊断、疫苗等板块业绩有复苏趋势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990646","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","01548","BK1161","LU0588546209.SGD","06996","01952","01801","02268","06990","00013","LU1242518857.USD","LU2543165471.USD","KCE","02273","09926","BK1515","09966","LU0039217434.USD","01530","09996","03759","BK1589","LU1251922891.USD","HK0000306685.HKD","LU0348783233.USD","SG9999004220.SGD","LU0327786744.USD","IE00B543WZ88.USD","LU1152091168.USD","LU0315179316.USD","LU1880383366.USD","01276","02269","HK0000320264.USD","LU0856984785.SGD","06821","01177","06078","02596","03329","02162","KURE","01093","BK1209","IE00B5MMRT66.SGD","LU0307460666.USD","02096","IE00B0JY6N72.USD","01951","06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388377","title":"勁方醫藥-B(02595)存倉市值總計19.55億港元 股東將4373.09萬股股票存入渣打銀行(香港)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388377","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388377?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 08:34","pubTimestamp":1788482051,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,9月3日,劲方医药-B(02595)出现存仓异动,存仓市值总计19.55亿港元,占比19.65%。该公司股东将4373.09万股股票存入渣打银行(香港),持股比例增加12.44%。劲方医药此前发布公告,GFH375已进入一线治疗KRAS G12D突变型晚期非小细胞肺癌(NSCLC)的II期研究,包括单药疗法、联合EGFR单抗(西妥昔单抗)或联合化疗(培美曲塞)三种治疗方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","BK1515","02595","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803502","title":"醫藥代表退場,基藥目錄「及時雨」能否解藥企之渴?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803502","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803502?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 23:41","pubTimestamp":1788450086,"startTime":"0","endTime":"0","summary":"02 8年磨一剑,基药目录送来“及时雨”恰在此时,基药目录更新了。二是基药目录首次纳入创新药。集采中标、医保谈判、基药目录入围构成了药品放量的三大政策通道。白马认为,基药目录的“及时雨”能解药企一时之渴,却解不了长期之渴。当医药代表退场的尘埃落定,当“带金销售”彻底成为过去式,真正能笑到最后的,是那些产品过硬、证据扎实、推广合规的药企。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788329362059116704","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["159938","BK1515","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664083968","title":"白雲山:2026年半年度權益分派實施公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2664083968","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664083968?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 21:32","pubTimestamp":1788442320,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月3日,白云山发布2026年半年度权益分派实施公告称,本次利润分配以方案实施前的公司总股本1,625,790,949股为基数,每股派发现金红利0.30元(含税),共计派发现金红利487,737,284.70元(含税)。股权登记日为2026年9月9日,除权(息)日为2026年9月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-03/doc-iniqqfvs6793255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00874","BK1521","BK0183","BK0070","BK0196","BK0096","BK1606","BK1515","BK0028","BK1191","BK1197","600332","BK0175","BK0239","BK0012","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874372","title":"九州通與京東健康簽署戰略合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874372","media":"南方财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874372?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 20:09","pubTimestamp":1788437340,"startTime":"0","endTime":"0","summary":"南方财经9月3日电,据九州通医药集团消息,9月3日,九州通医药集团(简称“九州通”)与京东健康签署战略合作协议。双方将共同整合渠道、供应链、技术与金融服务等领域的核心优势,围绕供应链、履约、消费场景与数智化采购等场景进行多维度深化协同,不断探索新模式、优化产业链效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864255516.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864255516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1571","BK1515","BK0250","LU0051755006.USD","BK0183","BK0028","SGXZ62798434.SGD","86618","BK0077","SGXZ86797644.SGD","BK1591","BK0146","BK0201","BK0188","BK1615","600998","BK0196","BK1589","BK1583","BK0187","BK1247","LU0456827905.SGD","BK0097","BK0039","06618","BK1142","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664787979","title":"王磊增持華潤萬象生活(01209)5萬股 每股作價38.52港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664787979","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664787979?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:30","pubTimestamp":1788435038,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新数据显示,9月1日,王磊增持华润万象生活(01209)5万股,每股作价38.52港元,总金额为192.6万港元。增持后最新持股数目约为5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1247","00241","EWH","HK0000165453.HKD","LU0620787316.HKD","BK1615","BK1617","BK1258","01209","LU0051755006.USD","BK1501","LU0164939612.USD","BK1584","BK1589","BK1189","BK1502","BK1542","LU0082770016.SGD","BK1229","LU0456827905.SGD","BK1591","BK1610","BK1515","LU0082770016.USD","BK1583","LU0456846285.SGD","BK1571","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664879974","title":"勁方醫藥-B(02595)9月3日斥資54.64萬港元回購2萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879974","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664879974?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 19:21","pubTimestamp":1788434461,"startTime":"0","endTime":"0","summary":"智通财经APP讯,劲方医药-B(02595)发布公告,于2026年9月3日斥资54.64万港元回购2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491703.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","159938","BK1574","02595","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875081","title":"白雲山:每股派0.30元,股權登記日為9月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875081","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875081?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 18:15","pubTimestamp":1788430500,"startTime":"0","endTime":"0","summary":"南财智讯9月3日电,白云山发布2026年半年度权益分派实施公告,每股派0.30元(含税),股权登记日为9月9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864171782.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864171782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK0196","BK0188","BK1191","BK1197","BK0028","BK0175","600332","BK0096","BK1515","BK0239","BK0097","BK0070","BK0183","BK0012","BK1521","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878268","title":"貝萊德在國藥控股的H股好倉比例下降0.18%至8.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878268","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878268?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:24","pubTimestamp":1788427440,"startTime":"0","endTime":"0","summary":"南财智讯9月3日电,香港交易所披露信息显示,BlackRock,Inc.(贝莱德)在国药控股的H股好仓(L)比例于8月31日从9.11%下降至8.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864136039.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864136039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","01099","LU1115378108.SGD","BK1500","LU0640798160.USD","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781028","title":"復星醫藥(02196.HK):蘆沃美替尼片新增適應症獲註冊批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781028","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664781028?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 17:22","pubTimestamp":1788427355,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1593","02196","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664264827","title":"復星醫藥(600196.SH)子公司蘆沃美替尼片新增適應症獲註冊批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2664264827","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664264827?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 16:21","pubTimestamp":1788423715,"startTime":"0","endTime":"0","summary":"智通财经APP讯,复星医药(600196.SH)发布公告,近日,公司控股子公司上海复星医药产业发展有限公司就芦沃美替尼片(商品名:复迈宁、项目代号:FCN-159)新增适应症的药品注册申请获国家药品监督管理局批准,本次获批的新适应症为用于伴有症状、无法手术的丛状神经纤维瘤(PN)的I型神经纤维瘤病(NF1)成人患者。该药品为集团自主研发的创新型小分子化学药物,为MEK1/2选择性抑制剂。本次新增适应症获批,可为中国境内相关罕见肿瘤患者提供新的治疗选择,并进一步增强该药品的市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","02196","BK0187","BK0183","BK0239","BK0060","BK0028","BK0012","BK0096","BK0175","BK1191","BK1593","BK1515","BK0196","600196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824858","title":"港股異動 | 同源康醫藥-B(02410)午後升逾9% EGFR-TKI氘申艾替尼獲批一線治療晚期非小細胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824858","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664824858?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:30","pubTimestamp":1788417020,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,同源康医药-B午后涨超9%。消息面上,同源康医药近日宣布,公司自主研发的新一代EGFR-TKI创新药甲磺酸氘申艾替尼片已正式获得中国国家药品监督管理局批准附条件上市,适应症为具有表皮生长因子受体外显子19缺失或外显子21置换突变,并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌成人患者的一线治疗。同源康预计收取7亿元人民币现金首付款及股份认购款,以及最高20.6亿元人民币的注册里程碑付款。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491413.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02410","09939","BK1574","BK4588","BK1515","VXUS","159938","BK1161","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664014829","title":"大行評級丨高盛:下調歌禮制藥目標價至13.86港元,維持「中性」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2664014829","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664014829?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 14:04","pubTimestamp":1788415446,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["01672","BK1191","BK1161","01477","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664826791","title":"同仁堂科技:營銷體系再升級 品種全生命周期管理提質增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2664826791","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664826791?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 12:35","pubTimestamp":1788410100,"startTime":"0","endTime":"0","summary":"变局求生,变局图强。2026年上半年,面对中成药行业流通渠道的深刻变革,北京同仁堂科技发展股份有限公司(以下简称“同仁堂科技”)正式启动“品种全周期管理体系”建设,构建从生产端至销售端的一体化链条,在渠道变局中展现出经营韧性与增长质量。“对市场的反应更灵敏、对客户的需求响应更及时、对终端的赋能更有针对性。最终,就是让对的产品,在对的时间,由合适的合作伙伴,最终送到消费者手中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033863901269.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033863901269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01666","BK1515","BK1583","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282653","title":"《半日速報》恒指半日收報25,317點 升6點; 恒生科技指數半日收報4,491點 跌25點 平安升逾3% 小米集團跌逾3% 卓越睿新、德翔海運、TCL電子創新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282653","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664282653?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 12:12","pubTimestamp":1788408720,"startTime":"0","endTime":"0","summary":"恒指半日收25,317点,升6点或0.0%。恒生科技指数报4,491点,跌25点或0.6%。国指跌27点或0.3%,报8,423点。沽空资料截至 2026-09-02 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542745/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542745/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0106252389.USD","LU1568876251.USD","LU0307460666.USD","TCHmain","LU0130518102.USD","SGXZ62798434.SGD","LU0067412154.USD","BK1190","LU2237443978.SGD","LU0441854154.USD","BK1258","LU1439103000.SGD","IE0008368742.USD","LU1820825898.SGD","LU0588546209.SGD","LU0516422366.SGD","GB00BDT5M118.USD","LU0128522157.USD","HSTECH","LU1720051108.HKD","LU0251144936.SGD","SG9999004220.SGD","SG9999006514.SGD","LU2293587155.HKD","BK1229","SG9999000459.SGD","SG9999002463.SGD","LU0898667661.SGD","LU1044875133.USD","LU0509642566.USD","LU1226287529.USD","LU0196878994.USD","LU1439102457.SGD","LU0700851271.USD","LU0163747925.USD","HK0000151867.HKD","LU0594300179.USD","SG9999017495.SGD","BK1516","LU0348788117.USD","03121","LU0762541174.USD","LU1568876335.HKD","LU2051468812.USD","LU1303224171.USD","LU0831103253.SGD","MIUmain","SG9999002562.SGD","LU0561508036.HKD","LU2125910500.SGD","LU0117841782.USD","LU1522347837.USD","LU1688375341.USD","LU1064130708.USD","LU0048597586.USD","LU0329678170.USD","LU0791591158.USD","LU1152091754.HKD","LU1282649810.SGD","LU0173614495.USD","LU0359201612.USD","IE0003895053.USD","LU0210533765.USD","LU0880133367.SGD","SG9999002828.SGD","01093","IE00BMCWC346.EUR","LU0345769128.USD","LU0572939691.SGD","LU0683595622.HKD","LU1171460220.USD","LU1956131251.USD","LU0165289439.USD","LU1251922891.USD","601600","LU1226288170.HKD","LU0011963245.USD","LU2153591404.USD","LU0786609619.USD","LU0588545730.USD","LU2279701549.SGD","BK1184","LU0633140560.USD","LU1048596156.SGD","LU0878004406.USD","BK1587","IE0008368304.USD","LU2237443622.USD","SGXZ99366536.SGD","03417","LU0164880469.USD","LU0702159699.USD","LDEM","SG9999009443.AUD","LU0235996351.USD","LU0106959298.USD","IE0008368411.USD","LU0640798160.USD","LU2177674079.SGD","LU1242518931.SGD","SG9999007991.SGD","LU0080751232.USD","LU0611395673.USD","HK0000165453.HKD","LU2251237306.USD","LU1808992512.USD","DRGN","LU0348814723.USD","LU0070217475.USD","LU1951186391.HKD","LU0107464264.USD","LU0320764599.SGD","LU2125910849.SGD","BK1164","HK0000914660.USD","00939","LU1102505762.USD","02600","IE0008369823.USD","IE00BZ08YS42.EUR","BK1584","BK1191","LU2348773727.SGD","LU2929501877.USD","LU1769817179.HKD","LU2257852520.SGD","IE00BPRC5H50.USD","LU1961090484.USD","LU1960683339.HKD","LU1515016050.SGD","SG9999013353.USD","LU1769817096.USD","07552","BK1502","BK1592","LU0708995583.HKD","LU1868838027.USD","LU1481107354.HKD","01070","LU1226288253.USD","03143","BK1560","LU0607220059.USD","IE00B0169L03.USD","LU2088748293.HKD","LU0417516571.SGD","LU0672654166.SGD","LU0862451837.USD","LU0762542818.HKD","HK0000914686.HKD","LU1146622755.USD","SOCL","LU0594300419.USD","LU0823397285.USD","LU0463099449.HKD","SG9999001226.SGD","LU0890818403.SGD","LU0254981946.USD","LU0791590937.USD","LU0188438112.USD","LU0572940350.SGD","LU1064131003.USD","LU1813983027.USD","LU2133065610.SGD","LU0456842615.SGD","LU0862451753.SGD","LU2023250504.SGD","03419","LU0205439572.USD","LU0516423174.USD","LU0348783233.USD","LU0348735423.USD","LU0868486357.SGD","BK1568","LU1497733557.USD","03993","LU1831875114.USD","LU2237443465.HKD","LU2476274720.SGD","LU0348825331.USD","LU0054237671.USD","LU2424517915.HKD","BK1095","LU0315178854.USD","LU1880398554.USD","LU0620787316.HKD","SG9999001903.USD","SG9999000327.SGD","BK1586","SG9999001846.SGD","LU0049853897.USD","SGXZ86797644.SGD","LU1196710351.USD","LU0228659784.USD","LU0630378692.HKD","01378","LU0762540952.USD","LU2097828631.EUR","TCOM","HTCD.SI","LU2045819591.USD","LU0865486749.SGD","LU0327786744.USD","LU1974910355.USD","LU0082770016.SGD","LU0823426480.USD","LU0784639295.USD","LU1634259391.SGD","IE00B29SXG58.USD","LU0675040207.SGD","LU1048484197.HKD","LU0348784397.USD","IE00BVYPNQ40.USD","LU0979878070.USD","BK1555","LU0143863198.USD","LU0287142896.SGD","LU0605514214.HKD","TCHI","SGXZ51526630.SGD","LU0819121731.USD","BK1240","601318","EMC","LU0269904917.USD","LU0048388663.USD","LU1044874839.SGD","LU2476274308.USD","LU0132412106.USD","BK1610","09088","02800","IE00B0169N27.USD","LU0084288322.USD","LU2294711473.HKD","LU1733274390.USD","LU1323998911.USD","02837","LU1993786604.SGD","SBHMY","02255","LU1629966141.USD","LU2008162690.USD","SG9999001051.SGD","LU0320764755.SGD","HK0001040143.USD","IE0009570106.USD","LU0164865239.USD","LU0823040885.USD","LU0918141887.USD","LU0886674414.USD","BK1588","BK1231","LU1814569148.SGD","HK0000107257.USD","LU0831093199.SGD","LU1718418525.SGD","LU2088747725.USD","LU0823413587.USD","BK1521","LU1810669033.SGD","IE00B19Z5X02.USD","SG9999001689.USD","BK1589","IE0003795394.USD","09988","LU0164939612.USD","LU2088748020.USD","LU0630314457.HKD","LU2362541273.HKD","LU2351347302.SGD","BK1607","00688","SG9999015952.SGD","LU1720051017.SGD","LU0345776255.USD","LU0214875030.USD","01177","BK1604","03067","LU0314109678.HKD","BK1608","IE00B8HQ1Z84.USD","LU0588545490.SGD","LU0043850808.USD","LU0203345920.USD","02318","KWEB","SG9999003461.SGD","LU1051769294.HKD","LU0499858438.USD","03037","BK1507","HK0000352382.USD","07226","LU0261950470.USD","LU1235295612.USD","SG9999009997.SGD","LU0047713382.USD","LU0543330483.HKD","LU1508157978.USD","LU1720050803.USD","513600","AAXJ","LU0029874905.USD","LU1366334578.USD","CXSE","LU0051755006.USD","LU0210526637.USD","LU2106854487.HKD","HK0000352291.HKD","LU1770034418.SGD","IE00BZ08YR35.GBP","JADE","LU2488822045.USD","LU0455707207.USD","LU0499858602.USD","BK1175","BK1249","LU0456827905.SGD","SG9999002950.SGD","LU0096374516.USD","JEMA","LU0049112450.USD","LU1328615791.USD","HXXD.SI","BK1523","GAMR","LU0143863784.USD","LU2462611646.USD","LU0348827113.USD","LU0873338254.USD","LU2097828805.USD","LU0082770016.USD","FFEM","00700","LU0345775950.USD","LU0348816934.USD","SG9999014674.SGD","SG9999018865.SGD","LU0117844026.USD","LU0737861699.HKD","LU2213484517.USD","BK1542","LU2097828557.USD","IE00B3M56506.USD","LU1634259557.SGD","LU1868837565.USD","LU1770036033.HKD","03032","LU1152091168.USD","BK1526","LU2097828714.EUR","IE0032431581.USD","LU0823038988.USD","LU0169518387.USD","82800","LU1196710195.USD","LU1282651048.USD","LU0572944931.SGD","LU2251237488.HKD","IE00B031J352.USD","LU1224444064.USD","LU2152927971.USD","LU0348723411.USD","LU0127658192.USD","LU1504937902.USD","BABA","LU2237443895.HKD","IE00BMPRXN33.USD","BK1575","BK1618","LU0871576103.HKD","LU1880383440.USD","LU0315179316.USD","IE00B543WZ88.USD","603993","LU2778985437.USD","LU0737861772.HKD","IE00BQJZWZ67.USD","83115","LU1226288097.SGD","IE00BMPRXR70.SGD","LU0048575426.USD","LU1804176565.USD","BK1096","IE00B5MMRT66.SGD","LU2247934214.USD","HK0000306685.HKD","LU0577902538.SGD","LU0469268626.HKD","BK1591","LU1366334651.USD","SGXZ31699556.SGD","03423","LU0449515922.USD","SG9999015986.USD","HSI","LU0261947096.USD","BK1506","LU0320764243.SGD","SG9999014914.USD","LU0828237940.HKD","LU1102505929.USD","LU0039217434.USD","LU0326948709.USD","LU0348805143.USD","LU2087589342.USD","LU0797268264.HKD","LU0821914370.USD","LU0348783662.USD","LU0501845795.SGD","LU0293314216.USD","LU3227948356.SGD","09926","LU0052750758.USD","LU0431992006.USD","LU1224709979.USD","LU1282648689.USD","BK1557","LU1691799644.USD","LU0516422952.EUR","LU0588545904.SGD","LU0577902298.EUR","LU0348766576.USD","IE00B0JY6N72.USD","LU0828237510.HKD","LU1868837722.USD","03088","HK0000288784.HKD","IE0001KFT4U8.USD","LU0882747503.HKD","LU1226287792.SGD","LU0648000940.SGD","LU2242644610.SGD","LU0577902611.USD","LU0211331839.USD","IE00BVYPNP33.GBP","LU0211977185.USD","IE0034224299.USD","CICHY","LU1642822792.SGD","SG9999010078.USD","LU1201861165.SGD","LU0072462343.USD","LU0203347892.USD","02687","ESPO","LU0634319403.HKD","LU1316542783.SGD","LU2237443549.SGD","BK1142","LU0650527681.SGD","ODDS","LU1048588211.SGD","LU0541501648.USD","LU1115378108.SGD","LU0417516738.SGD","LU0417516902.SGD","LU2039709279.SGD","LU2399975544.HKD","LU0414403682.SGD","LU0823426308.USD","LU0577902371.SGD","LU1497733631.SGD","LU0264606111.USD","LU2362541513.USD","LU0228367735.SGD","LU0329678337.USD","09961","BK1550","EEMX","SG9999001093.SGD","LU1880398471.USD","BK1501","IE00BGV7N243.SGD","LU0149721374.USD","LU0396098781.USD","LU2265009873.SGD","LU1328277881.USD","LU1917777945.USD","LU0608807946.USD","IE00B97KM107.HKD","LU0630378429.USD","BK1161","LU0061477393.USD","LU0175139822.USD","LU0823041008.USD","LU0029875118.USD","CAOVY","09067","FDNI","LU1675838814.USD","LU1226287875.USD","LU1807302812.USD","LU1188198961.HKD","LU0856984785.SGD","LU0106259558.USD","SG9999015945.SGD","MCHmain","SG9999001069.SGD","LU0516422440.USD","BK1228","LU0708995153.HKD","XIACY","LU0244354667.USD","LU0231483743.USD","BK1500","LU0370786039.SGD","89988","LU0345780950.USD","LU0477156797.USD","SG9999010052.SGD","IE00B067MR52.USD","LU1497734951.SGD","LU1794554557.SGD","LU0642271901.SGD","BK1609","LU0164872284.USD","IE00BZ08YT58.USD","LU1023057109.AUD","LU0577902454.USD","LU2317271919.USD","LU0140636845.USD","SGXZ90724238.SGD","IE00BQXX3D17.EUR","LU0130103400.USD","LU0828238088.HKD","BK1193","LU2097829019.USD","LU0819123356.HKD","LU0648948544.HKD","LU0259732245.USD","HK0000320264.USD","LU0289960550.SGD","LU2153592121.USD","LU2498475776.HKD","LU0048580855.USD","IE00BQXX3F31.USD","SG9999014906.USD","IE00BWDBJ730.SGD","HK0000306701.USD","LU1880383366.USD","IE00BYV24P56.USD","LU1719994722.HKD","09115","81810","LU0918141705.HKD","LU0651947912.USD","PAImain","LU2237443382.USD","LU1046422090.SGD","LU0456846285.SGD","HK0001040168.HKD","07500","IE00BF5LJ272.USD","LU3063872942.SGD","LU0531970944.HKD","LU1733274473.HKD","LU0823413660.USD","LU1008478684.HKD","03115","LU0197773160.USD","LU2187417386.USD","LU0149534421.HKD","TCEHY","BK1570","SG9999014880.SGD","LU2148510915.USD","BIDD","LU1883866441.USD","SG9999004311.SGD","BK1513","LU1655091459.SGD","LU0878005551.USD","LU0197773673.USD","LU0823397103.USD","BK1574","LU0054450605.USD","01209","LU0384037296.USD","LU0328353924.USD","LU0540923850.HKD","LU0593848301.USD","LU0345781412.USD","LU0972618739.USD","LU1211504680.USD","LU2088747998.USD","IE00BGHQDM52.EUR","03145","LU1734074674.USD","SGXZ81514606.USD","BK1517","82318","SG9999006597.SGD","SG9999015978.USD","HHImain","LU0651946864.USD","LU0502904849.HKD","IE0031814852.USD","LU1105468828.SGD","BK1241","HK0000320223.HKD","LU2449936058.SGD","LU1282649141.HKD","SG9999011746.SGD","LU0608807433.USD","IE00B031HW06.USD","ALBmain","LU1548497426.USD","HK0000288743.USD","SG9999014898.SGD","LU0589944569.HKD","LU0348767384.USD","LU2226246903.HKD","LU0326950275.SGD","BK1594","IE00B031HY20.USD","02833","BK1103","PNGAY","LU0251143458.SGD","LU1725190679.HKD","LU2348774022.SGD","LU2279858448.HKD","LU1242518857.USD","LU0516423091.SGD","HPAD.SI","IE00BQXX3C00.GBP","02510","LU0128522744.USD","07300","LU1196710864.SGD","LU2362540622.SGD","LU1282649067.USD","SG9999000418.SGD","XSOE","IE0003851619.USD","01109","IE0032834883.USD","LU0488056044.USD","LU0210527791.USD","LU2357305700.SGD","EMCS","LU1051768304.USD","IE00B8L5B284.USD","BK1615","LU0531971595.HKD","LU2663582299.SGD","LU0543330566.HKD","LU0633140727.USD","LU1785774172.SGD","03033","LU1166156734.SGD","CRBJY","LU1044876610.USD","LU0985320562.USD","LU0072913022.USD","LU0823039010.USD","SG9999000475.SGD","LU0541502299.USD","LU0181495838.USD","LU0261950983.USD","BKF","LU2097828474.EUR","601939","01810","LU0229945570.USD","KURE","LU0359201885.HKD","LU2088748376.SGD","BK1531","SG9999018857.SGD","LU0359202008.SGD","HK0000286598.CNH","BK1515","HBBD.SI","LU0738912210.USD","BK1583","LU1981816686.USD","LU0192582467.USD","LU0449509016.USD","LU0345769631.USD","LU1282651121.HKD","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664823083","title":"星展銀行上調比亞迪電子目標價至40港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823083","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664823083?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 11:14","pubTimestamp":1788405278,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1504","BK1580","BK1607","LU0274383008.USD","LU0348767384.USD","BK1515","00285","LU0348766576.USD","BK1582","BK1149","BK1589","BK1167","BK1540"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664823065","title":"港股異動 | 石藥集團(01093)升逾4% SYS6010近日再獲國家藥監局納入突破性治療品種名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823065","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664823065?lang=zh_tw&edition=fundamental","pubTime":"2026-09-03 11:14","pubTimestamp":1788405245,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,石药集团涨超4%,截至发稿,涨4.09%,报9.545港元,成交额7.59亿港元。消息面上,石药集团发布公告,本集团开发的SYS6010(该产品)近日再获中国国家药品监督管理局纳入突破性治疗品种名单,拟定适应症为既往接受过免疫及含铂化疗治疗失败的复发或转移性头颈鳞癌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KURE","IE00BZ08YS42.EUR","LU2039709279.SGD","LU1152091754.HKD","HK0000165453.HKD","LU0314109678.HKD","BK4588","LU1226287875.USD","BK1521","LU0140636845.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","BK1515","SG9999004220.SGD","BK4585","LU1226288170.HKD","LU1226287792.SGD","IE0008369823.USD","LU1008478684.HKD","BK1191","LU1813983027.USD","LU0326950275.SGD","LU1152091168.USD","IE0008368742.USD","LU1807302812.USD","IE00B5MMRT66.SGD","LU0315179316.USD","01093","LU1960683339.HKD","LU0072913022.USD","VXUS","KCAI","LU1951186391.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU0880133367.SGD","IE00B543WZ88.USD","LU1226287529.USD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}